Prebiotics and probiotics: their role in the management of gastrointestinal disorders in adults.

Hdl Handle:
http://hdl.handle.net/10147/237793
Title:
Prebiotics and probiotics: their role in the management of gastrointestinal disorders in adults.
Authors:
Quigley, Eamonn M M
Affiliation:
Alimentary Pharmabiotic Centre, Department of Medicine,Cork University Hospital, Cork, Ireland. e.quigley@ucc.ie
Citation:
Prebiotics and probiotics: their role in the management of gastrointestinal disorders in adults. 2012, 27 (2):195-200 Nutr Clin Pract
Journal:
Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition
Issue Date:
Apr-2012
URI:
http://hdl.handle.net/10147/237793
DOI:
10.1177/0884533611423926
PubMed ID:
22127952
Abstract:
For decades, if not centuries, a variety of products with what would now be regarded as prebiotic and probiotic properties have been consumed by the general public and advocated for their benefits on health and, in particular, gastrointestinal well-being. More recently, medical science has taken a great interest in the population of micro-organisms, the gut microbiota that normally populates the human gut, and the range of important functions carried out by the microbiota in health is being progressively defined. As a corollary, the list of disorders and diseases that may result from disruption of the normal microbiota and/or its interaction with the host continues to grow. A scientific basis for the use of probiotics and prebiotics is, therefore, beginning to emerge. Unfortunately, although progress has been made, the clinical evidence to support the use of these preparations lags behind. Nevertheless, a number of human disease states may benefit from the use of probiotics, most notably, diarrheal illnesses, some inflammatory bowel diseases, certain infectious disorders, and irritable bowel syndrome. Prebiotics promote the growth of "good" bacteria, and although a variety of health benefits have been attributed to their use, prebiotics have been subjected to few large-scale clinical trials.
Item Type:
Article
Language:
en
MeSH:
Adult; Bacteria; Diarrhea; Gastrointestinal Diseases; Gastrointestinal Tract; Humans; Infection; Inflammatory Bowel Diseases; Irritable Bowel Syndrome; Prebiotics; Probiotics
ISSN:
1941-2452

Full metadata record

DC FieldValue Language
dc.contributor.authorQuigley, Eamonn M Men_GB
dc.date.accessioned2012-08-08T15:20:07Z-
dc.date.available2012-08-08T15:20:07Z-
dc.date.issued2012-04-
dc.identifier.citationPrebiotics and probiotics: their role in the management of gastrointestinal disorders in adults. 2012, 27 (2):195-200 Nutr Clin Practen_GB
dc.identifier.issn1941-2452-
dc.identifier.pmid22127952-
dc.identifier.doi10.1177/0884533611423926-
dc.identifier.urihttp://hdl.handle.net/10147/237793-
dc.description.abstractFor decades, if not centuries, a variety of products with what would now be regarded as prebiotic and probiotic properties have been consumed by the general public and advocated for their benefits on health and, in particular, gastrointestinal well-being. More recently, medical science has taken a great interest in the population of micro-organisms, the gut microbiota that normally populates the human gut, and the range of important functions carried out by the microbiota in health is being progressively defined. As a corollary, the list of disorders and diseases that may result from disruption of the normal microbiota and/or its interaction with the host continues to grow. A scientific basis for the use of probiotics and prebiotics is, therefore, beginning to emerge. Unfortunately, although progress has been made, the clinical evidence to support the use of these preparations lags behind. Nevertheless, a number of human disease states may benefit from the use of probiotics, most notably, diarrheal illnesses, some inflammatory bowel diseases, certain infectious disorders, and irritable bowel syndrome. Prebiotics promote the growth of "good" bacteria, and although a variety of health benefits have been attributed to their use, prebiotics have been subjected to few large-scale clinical trials.en_GB
dc.language.isoenen
dc.rightsArchived with thanks to Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutritionen_GB
dc.subject.meshAdult-
dc.subject.meshBacteria-
dc.subject.meshDiarrhea-
dc.subject.meshGastrointestinal Diseases-
dc.subject.meshGastrointestinal Tract-
dc.subject.meshHumans-
dc.subject.meshInfection-
dc.subject.meshInflammatory Bowel Diseases-
dc.subject.meshIrritable Bowel Syndrome-
dc.subject.meshPrebiotics-
dc.subject.meshProbiotics-
dc.titlePrebiotics and probiotics: their role in the management of gastrointestinal disorders in adults.en_GB
dc.typeArticleen
dc.contributor.departmentAlimentary Pharmabiotic Centre, Department of Medicine,Cork University Hospital, Cork, Ireland. e.quigley@ucc.ieen_GB
dc.identifier.journalNutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutritionen_GB
dc.description.provinceMunsteren

Related articles on PubMed

All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.